GANDOLFI, LISA
 Distribuzione geografica
Continente #
NA - Nord America 582
EU - Europa 235
AS - Asia 86
SA - Sud America 2
AF - Africa 1
OC - Oceania 1
Totale 907
Nazione #
US - Stati Uniti d'America 577
IT - Italia 102
UA - Ucraina 42
CN - Cina 35
DE - Germania 26
HK - Hong Kong 20
FI - Finlandia 16
SG - Singapore 16
IE - Irlanda 15
SE - Svezia 13
GB - Regno Unito 8
IN - India 6
CA - Canada 5
CZ - Repubblica Ceca 5
FR - Francia 5
JP - Giappone 3
TR - Turchia 3
BR - Brasile 2
AU - Australia 1
IR - Iran 1
KR - Corea 1
LV - Lettonia 1
MD - Moldavia 1
MU - Mauritius 1
RU - Federazione Russa 1
TH - Thailandia 1
Totale 907
Città #
Fairfield 96
Ashburn 56
Wilmington 49
Chandler 47
Woodbridge 44
Jacksonville 35
Seattle 34
Houston 30
Princeton 29
New York 24
Cambridge 23
Hong Kong 20
Brescia 17
Helsinki 16
Dublin 15
Beijing 14
Ann Arbor 9
Boardman 9
Shanghai 9
Singapore 9
Des Moines 6
Genoa 6
Milan 6
Rome 5
Battipaglia 4
Brno 4
Pune 4
Brendola 3
Brooklyn 3
Falkenstein 3
Jinan 3
Kocaeli 3
San Francisco 3
Toronto 3
Viterbo 3
Bergamo 2
Casanova Lonati 2
London 2
Lovere 2
Mumbai 2
Nanjing 2
Pescara 2
San Diego 2
Shenyang 2
São Paulo 2
Tokyo 2
Vicenza 2
Boston 1
Castiglione Delle Stiviere 1
Catania 1
Chicago 1
Chiswick 1
Civitavecchia 1
Gossolengo 1
Hebei 1
Hillsborough 1
Kilburn 1
Kish 1
Kōriyama 1
La Spezia 1
Leawood 1
Lequio Tanaro 1
Los Angeles 1
Melbourne 1
Munich 1
Ningbo 1
North York 1
Norwalk 1
Olomouc 1
Padova 1
Pesaro 1
Redwood City 1
Riga 1
Spoltore 1
Tianjin 1
Tiraspol 1
Verona 1
Yangsan 1
Totale 699
Nome #
Feasibility of tumor‑derived exosome enrichment in the onco‑hematology leukemic model of chronic myeloid leukemia 115
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS 98
First Interim Report of the Italian Multicentric Phase-III Randomized Study to Optimize TKIs Multiple Approaches - (OPTkIMA) in Elderly Patients (older than 60 years) with Ph+ Chronic Myeloid Leukemia (CML) and MR3.0/ MR4.0 Stable Molecular Response 95
RT-qPCR versus Digital PCR: How Do They Impact Differently on Clinical Management of Chronic Myeloid Leukemia Patients? 79
Advances in CMV Management: A Single Center Real-Life Experience 76
Biological versus Clinical Risk Factors in Acute Myeloid Leukemia: Is There a Winner? 66
ANTI-CMV Immunoglobulins in Association with ANTI-CMV Drugs in Patients with Hematological Malignancies Submitted to Allogeneic STEM CELL Transplantation: A MULTI-Center Retrospective Experience 66
OPTIMIZATION OF TKI TREATMENT IN ELDERLY PATIENTS WITH PH+ CHRONIC MYELOID LEUKEMIA AND STABLE MR3.0 OR MR4.0: 1ST YEAR RESULTS OF THE ITALIAN MULTICENTRIC PHASE-III RANDOMIZED OPTKIMA STUDY 58
Liposomal doxorubicin for the treatment of iatrogenic kaposi sarcoma following hematopoietic stem cell transplantation 54
Case Report: Late Onset of Myelodysplastic Syndrome From Donor Progenitor Cells After Allogeneic Stem Cell Transplantation. Which Lessons Can We Draw From the Reported Case? 47
Multidimensional geriatric assessment for elderly hematological patients (≥60 years) submitted to allogeneic stem cell transplantation. A French-Italian 10-year experience on 228 patients 46
Severe Acute Respiratory Syndrome Coronavirus-2 Pandemia: Facts and Perspectives in a Bone Marrow Transplant Unit 40
PF404 TUMOR-DERIVED EXOSOMES MAY BE USED AS NEW INFORMATIVE TOOL FOR THE DETECTION OF BONE MARROW RESIDUAL CML LEUKEMIC CELLS ACTIVITY 40
S882 OPTIMIZATION OF TKI TREATMENT IN ELDERLY PATIENTS WITH PH+ CHRONIC MYELOID LEUKEMIA AND STABLE MR3.0 OR MR4.0: 1ST YEAR RESULTS OF THE ITALIAN MULTICENTRIC PHASE-III RANDOMIZED OPTKIMA STUDY 27
Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs: First interim analysis of OPTkIMA study 25
Totale 932
Categoria #
all - tutte 6.002
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.002


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020154 0 0 4 10 15 14 12 11 23 32 13 20
2020/2021304 5 13 7 52 20 51 21 33 29 38 16 19
2021/2022141 14 6 1 15 4 12 4 9 7 26 11 32
2022/2023153 19 6 5 8 15 30 2 25 16 7 10 10
2023/2024180 12 6 18 11 10 45 9 5 30 1 2 31
Totale 932